An evidence review
Found Health Review: The $49 Plan Needs a Year and Insurance
Found's advertised $49 a month needs both a 12-month commitment and commercial insurance. Month-to-month it is $89, or $149 cash — and its own pages disagree.
Written by
Adrian ColeLead Research Editor
Adrian Cole is the pen name of Somnipeptide's lead research editor, who writes about growth-hormone secretagogues, sleep architecture, recovery, and longevity peptides.
Every claim cited to primary research ·
Contents
Editor's pick
CoreAge Rx
$99/mo flat
Doctor-reviewed sermorelin with flat pricing and built-in human support.
See CoreAge Rx pricing- Route
- Nightly subcutaneous injection
- Evidence
- Raises GH; sleep benefit unproven
- Price
- $99/mo flat · no membership
- Support
- Nurse + dietitian
Advertising disclosure — this is our affiliate partner, and we may earn a commission at no extra cost to you. It does not change what we say about them.
Another peptide source
Telos Rx
A wider compounded peptide catalog — sermorelin, ipamorelin, CJC-1295, MK-677 — dispensed by U.S.-licensed providers. Everything is compounded and not FDA-approved, and peptide pricing is not shown until after intake.
Explore Telos RxFound Health is a weight-loss programme and nothing else. Fourteen medications, every one of them for weight: compounded semaglutide, tirzepatide and liraglutide; branded Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza and Trulicity; oral Foundayo and Rybelsus; and four non-GLP-1 orals — Contrave, metformin, topiramate and zonisamide. There is no peptide here of any kind, no NAD+, and nothing for sleep, cognition, energy or longevity. If you came from the peptide side of this site, that is the whole answer, and our sermorelin board is where to go instead.
What is worth a review is the pricing, because Found is quoted everywhere at "$49 a month" and that figure needs two things at once, together: a twelve-month commitment and a commercial insurance card.
The $49, and the two gates in front of it
Found's own marketing page never mentions $49. The real table lives inside the binding Offer Terms, and it is published as an image rather than as text — which is one reason the figure circulates without its conditions attached. Read out of that document:
Generics plan — the oral non-GLP-1 medications, billed every four weeks:
- 1 month: $89 with commercial insurance, $149 cash. This is the month-to-month rate.
- 3 months: $79 / $139.
- 6 months: $69 / $129.
- 12 months: $49 / $99. This is the advertised number.
Compounded GLP-1 plan: 1 month $199 insured / $299 cash, falling to $149 / $199 on twelve months.
So $49 requires a twelve-month commitment and commercial insurance. Take away either and it is $99, $89 or $149. If you are cash-pay and want to try one month, the number is $149 — three times the headline.
What the $49 actually requires
| Term | With commercial insurance | Cash-pay | Advertised? |
|---|---|---|---|
| 1 month (month-to-month) | $89 | $149 | No |
| 3 months | $79 | $139 | No |
| 6 months | $69 | $129 | No |
| 12 months (= 48 weeks) | $49 | $99 | Yes — the "from" figure |
Two more traps inside the same table
Billing runs every four weeks, not monthly. Thirteen cycles a year rather than twelve, so every figure above buys thirteen charges annually. That is the single most common reason a "flat monthly price" costs more over a year than the arithmetic suggests, and it applies to the whole industry — we cover the same pattern on the peptide side in what sermorelin costs per month.
"Twelve months" is forty-eight weeks. Found's own terms define the twelve-month plan that way. Forty-eight weeks is about eleven calendar months of medication, so the annual plan is not a year's supply — it is a year's commitment to eleven months of drug.
Its own two pages disagree about the price
This one is not a nuance, it is a straight contradiction. Found's marketing pricing page advertises the compounded GLP-1 plan at $99 / $169 on twelve months and $199 / $289 monthly. The binding Offer Terms say $149 / $199 on twelve months and $199 / $299 monthly.
Three of the four cells disagree, and the Offer Terms are the document you are actually bound by. We publish the Offer Terms figures for that reason. If you sign up on the strength of the marketing page, check what the checkout charges before you confirm — the gap on the cash twelve-month tier alone is $30 a cycle, or about $390 across thirteen of them.
Where it is genuinely strong
Found names the most senior clinical advisers of anything this site links to. A senior medical advisor who formerly directed a board-certification programme in obesity medicine, a named medical director, and Columbia and Stanford faculty on the advisory side. Compared with most of this category — where the prescriber is "a US-licensed provider" and the pharmacy is "a 503A" — that is a real difference in kind.
It comes with a disclosure Found makes itself, which counts in its favour: the most senior of those advisors does not interact directly with patients. That is honest, and it is also the qualifier to hold onto when a famous name is used to sell a programme.
The molecules behind the compounded line have serious evidence — semaglutide and tirzepatide each have large randomised weight-loss trials12 — though those trials were run on the branded products, not on compounded copies, which is the distinction the whole compounded-GLP-1 market rests on and mostly does not mention.
We screened Found against the FDA warning-letter database on 8 August 2026, on a search validated against a known positive in the same pass3. Nothing on record.
The rest of the caveats
States. Insurance is accepted in 41 states, and that same page contradicts itself twice: one state renders an available-plans panel while being absent from the state selector, and another is listed as accepted while its own panel reads that no plans are available for it. Check yours before you pay.
The pharmacy is not named — but the claim Found makes about it is specific, and worth quoting because most operators do not make one. Its compounded-semaglutide page says Found "partners exclusively with 503A-licensed pharmacies", with third-party testing for potency, purity and sterility. That is a real representation about who fills your prescription, and a step above the general "state boards regulate 503A pharmacies" compliance sentence some competitors publish and reviewers mistake for the same thing. It is still less than a name.
Refunds are tight. Membership is refundable only within three days or before your first consult. Medication and lab kits are not refundable once shipped. Renewals are not refundable at all. Cancellation requires at least 48 hours' notice before a renewal.
Brand pricing is brand pricing. Roughly $1,100 a month cash for Ozempic and Mounjaro, from $650 for Wegovy and Zepbound, and about $149 for Foundayo. If insurance is the reason you are considering Found, that is where it earns its keep — and why insurance does not cover sermorelin is the mirror image of the same question on the peptide side.
Bottom line
$89 a month with commercial insurance or $149 cash is Found's real month-to-month price on the oral generics plan; the advertised $49 needs a twelve-month commitment and commercial insurance together. The compounded GLP-1 plan is $199 insured or $299 cash monthly. Billing runs every four weeks — thirteen charges a year — and its "twelve months" is forty-eight weeks. Its marketing page and its binding Offer Terms disagree on three of four price cells, so confirm at checkout. The named clinical bench is the strongest we link to anywhere. And it sells no peptide, no NAD+ and nothing for sleep, so for readers of this site it is a weight-loss route and nothing more.
Frequently asked questions
Is Found Health really $49 a month?
Only if you commit to twelve months and have commercial insurance. Both conditions have to hold. Month-to-month on the same oral generics plan it is $89 with insurance or $149 cash, and the twelve-month cash rate is $99. The figure comes from a pricing table published as an image inside Found's binding Offer Terms; the marketing page never mentions $49 at all.
What does Found charge for a compounded GLP-1?
Per the binding Offer Terms, $199 a month with commercial insurance or $299 cash on a month-to-month plan, falling to $149 and $199 on twelve months. Note that Found's own marketing pricing page advertises different numbers — $199/$289 monthly and $99/$169 on twelve months — so three of the four cells disagree between the two documents. The Offer Terms are the binding one.
Does Found bill monthly?
No, every four weeks — thirteen cycles a year rather than twelve. And its "twelve-month" plan is defined as forty-eight weeks, which is about eleven calendar months of medication, so an annual plan is not a year's supply.
Does Found Health sell peptides or NAD+?
No. Its catalogue is fourteen medications and every one is a weight-loss drug — compounded semaglutide, tirzepatide and liraglutide, seven branded GLP-1s, oral Foundayo and Rybelsus, and four non-GLP-1 orals. There is no sermorelin, no growth-hormone peptide, no NAD+ and nothing for sleep, cognition or longevity.
Which states does Found Health cover?
Insurance is accepted in 41 states, and that page contradicts itself twice: one state shows an available-plans panel while being absent from the state selector, and another is listed as accepted while its own panel says no plans are available. Confirm your state before paying.
Can you get a refund from Found?
Only narrowly. Membership is refundable within three days or before your first consult; medication and lab kits are non-refundable once shipped; renewals are not refundable at all. Cancellation needs at least 48 hours' notice before a renewal.
Notes & sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
- U.S. Food and Drug Administration (2026). Warning Letters (searchable database of letters issued to regulated companies).. FDA Inspections, Compliance, Enforcement, and Criminal Investigations. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Also in this collection
Shed (ShedRx) Review: The Advertised Price Is a 12-Month Rate
Shed advertises tirzepatide from $239 and semaglutide from $159. Both are twelve-month rates — its own terms put the monthly price at $299 and $199.
ReadStrut Health Review: Sermorelin Formats, Price and FDA Letter
Strut sells sermorelin as a $99 lozenge or a $119 injection. What the price covers, what its safety pages get right, and the February 2026 FDA letter.
ReadSprout Health Review: GLP-1 Pricing and the FDA Letter
Sprout Health sells compounded GLP-1s from $149 and brand Wegovy and Zepbound. The prices, the pay-then-qualify order, and the September 2025 FDA letter.
ReadMyDrHank Review: The $137 Price Is a Year Paid Up Front
MyDrHank advertises sermorelin from $137 a month. That is a 12-month prepay of $1,644 — the real month-to-month price is $199, published on no page.
ReadTesamorelin Cost: Branded Egrifta vs Compounded
Branded EGRIFTA SV runs thousands a month; compounded tesamorelin is far cheaper but unregulated. The honest cost picture and why insurance rarely helps.
ReadCare Bare Rx Review: $300 Sermorelin, Wrong Landing Page
Care Bare Rx sells a named sermorelin vial at $300 a month — behind a landing page advertising prices its own checkout will not sell you.
Read